Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19
NCT04645368
·
clinicaltrials.gov ↗
COMPLETED
Status
160
Enrollment
INDUSTRY
Sponsor class
Conditions
Fibroses, Pulmonary
Interventions
DRUG:
bovhyaluronidase azoxymer
Sponsor
NPO Petrovax